explore -WSS

explore

author：knowledge 2025-08-23 08:57:40 - browse：78294

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Sophia Smith scores twice for US in in 3

WSS

What Henrietta Lacks's story taught me about my role as a doctor

Men with early prostate cancer can safely opt out of treatment

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Wikipedia

explore

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Thousands protest mob assault of women who were paraded naked in remote Indian border state

What does generative AI mean for health care? We asked experts

Marc Tessier

Novavax promises a turnaround & Lilly roils the obesity market

FDA approves first blood sugar monitor without finger pricks

Sports medicine is finally prioritizing gender equality

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Walensky prepares to leave CDC — and Congress — behind

Behind warning on Apellis’s eye drug lies a conflict of interest

focus

Ending health disparities requires full federal government, panel says

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

The response to Covid

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

focus

Wikipedia

knowledge

Wikipedia